BIB

$109.88 4.11% $4.34
Aug 17, 2026 04:00 AM

BIB, or ProShares Ultra Biotech, is an exchange-traded fund (ETF) designed to provide twice the daily return of the S&P Biotechnology Select Industry Index. It is a leveraged ETF, aiming to deliver 2x the daily performance of the underlying index.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Aug 17, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Supercharge Your BIB Trading Now

Take control of your trading with OHLCX Platform. Our platform offers unparalleled analysis and technical support for BIB, designed to enhance your market performance. Transform your trading strategy now and experience the difference with our expert tools!

Discover More Now

Frequently Asked Questions

Investors can purchase shares of BIB through a brokerage account. It is traded on major stock exchanges under the ticker symbol "BIB" and can be bought and sold like other stocks and ETFs.

Risks include high volatility and the potential for substantial losses due to the leveraged nature of the ETF. BIB’s performance is highly sensitive to daily changes in the biotech sector, and its use of leverage can amplify both gains and losses.

Factors influencing BIB’s performance include movements in the biotechnology sector, changes in the S&P Biotechnology Select Industry Index, market volatility, and the effects of leverage. The ETF’s performance is also impacted by its daily rebalancing and compounding effects.

Historical performance data for BIB includes past returns, NAV, and volatility. Investors should review performance charts and reports to understand how BIB has tracked its leveraged objective over different time periods.

BIB rebalances its holdings daily to maintain its leverage ratio of 2x the daily performance of the S&P Biotechnology Select Industry Index. This daily rebalancing can lead to differences in performance over time compared to the index due to the effects of compounding.

Similar ETFs to BIB include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide three times the daily performance of the S&P Biotechnology Select Industry Index; IBB (iShares Nasdaq Biotechnology ETF), which tracks the Nasdaq Biotechnology Index and provides exposure to biotechnology and pharmaceutical companies; and XBI (SPDR S&P Biotech ETF), which tracks the S&P Biotechnology Select Industry Index and provides broad exposure to the biotech sector.

BIB is managed by ProShares and seeks to achieve its investment objective by using financial instruments, including derivatives such as futures contracts, options, and swap agreements. It aims to provide leveraged exposure to the biotechnology sector.

Key performance metrics for BIB include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. BIB's performance is designed to be twice that of the S&P Biotechnology Select Industry Index on a daily basis.

BIB aims to deliver twice the daily return of the S&P Biotechnology Select Industry Index. However, due to its leveraged nature, performance can diverge significantly over longer periods due to compounding effects and daily rebalancing.

BIB has an expense ratio of approximately 0.95%. This fee represents the cost of managing the fund, including administrative and operational expenses, and is expressed as a percentage of the fund’s average net assets.

Reveal Your BIB Trading Now

Experience the future of trading with OHLCX execution platform. Our advanced system delivers in-depth analysis and insights for BIB, utilizing state-of-the-art technical tools and strategies. Start optimizing your trades today and see how we can elevate your trading results!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.